{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:22:31Z","timestamp":1784607751807,"version":"3.55.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.survophthal.2007.06.004","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T07:15:09Z","timestamp":1187853309000},"page":"503-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["Triamcinolone Acetonide in Ocular Therapeutics"],"prefix":"10.1016","volume":"52","author":[{"given":"C.M.","family":"Jermak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Dellacroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.A.","family":"Peyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2007.06.004_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006982-200302000-00022","article-title":"Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis","volume":"23","author":"Alldredge","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajo.2003.08.035","article-title":"Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome","volume":"137","author":"Andrade","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/00912700022009413","article-title":"A mass balance study to evaluate the biotransformation and excretion of [14C]-triamcinolone acetonide following oral administration","volume":"40","author":"Argenti","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib4","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1167\/iovs.03-1110","article-title":"Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema","volume":"45","author":"Audren","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1600-0420.2006.00700.x","article-title":"Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial","volume":"84","author":"Audren","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2007.06.004_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","article-title":"The effect of intravitreal triamcinolone acetonide on intraocular pressure","volume":"34","author":"Bakri","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2007.06.004_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archopht.122.8.1137","article-title":"Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion","volume":"122","author":"Bashshur","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(71)91088-9","article-title":"Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture","volume":"1","author":"Becker","year":"1971","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","article-title":"Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection","volume":"110","author":"Beer","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","article-title":"Intravitreal triamcinolone for refractory pseudophakic macular edema","volume":"135","author":"Benhamou","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib11","article-title":"Intraocular pressure after low-dose 400ug intravitreal triamcinolone acetonide injection","author":"Bhavan","year":"2004","journal-title":"ARVO abstract"},{"key":"10.1016\/j.survophthal.2007.06.004_bib12","first-page":"1","article-title":"Editorial: The drainage of aqueous humor","volume":"14","author":"Bill","year":"1975","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0886-3350(03)00016-6","article-title":"Visualizing vitreous using Kenalog suspension","volume":"29","author":"Burk","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2007.06.004_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1442-9071.1998.tb01330.x","article-title":"Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up","volume":"26","author":"Challa","year":"1998","journal-title":"Aust NZ J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.eye.6701585","article-title":"Ocular-hypertensive response and corneal endothelial changes after intravitreal triamcinolone injections in Chinese subjects: a 6-month follow-up study","volume":"19","author":"Chan","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2007.06.004_bib16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bjo.2003.033589","article-title":"Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema","volume":"88","author":"Chen","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/bjo.2004.041707","article-title":"Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study","volume":"88","author":"Ciardella","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","article-title":"Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema","volume":"29","author":"Conway","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.survophthal.2007.06.004_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2133.1976.tb00830.x","article-title":"Glaucoma following the application of corticosteroid to the skin of the eyelids","volume":"95","author":"Cubey","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib21","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ajo.2004.01.008","article-title":"Serum levels of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Degenring","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00347-003-0862-7","article-title":"[Intraocular triamcinolone for diffuse diabetic macular edema]","volume":"101","author":"Degenring","year":"2004","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2007.06.004_bib23","first-page":"491","article-title":"El tratamento de enfermedads medicas con triamcinolone intravitrea","volume":"65","author":"Dominquez","year":"1993","journal-title":"Arch Doc Esp Oftalmol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2007.06.004_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/02713689208999526","article-title":"Adhesion molecules are expressed in the human retina and choroid","volume":"11","author":"Duguid","year":"1992","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2007.06.004_bib25","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","article-title":"Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone","volume":"88","author":"Ebner","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib26","first-page":"200","article-title":"Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells","volume":"66","author":"Elner","year":"1992","journal-title":"Lab Invest"},{"key":"10.1016\/j.survophthal.2007.06.004_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/00006982-200312000-00003","article-title":"Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases","volume":"23","author":"Enaida","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1442-9071.2004.00902.x","article-title":"Clinical trial to compare efficacy and side-effects of injection of posterior sub-Tenon triamcinolone versus orbital floor methylprednisolone in the management of posterior uveitis","volume":"32","author":"Ferrante","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0002-9394(14)74341-7","article-title":"Histopathologic features of subconjunctivally injected corticosteroids","volume":"103","author":"Ferry","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/clm.1996.14.323","article-title":"Vascular effects of photodynamic therapy","volume":"14","author":"Fingar","year":"1996","journal-title":"J Clin Laser Med Surg"},{"key":"10.1016\/j.survophthal.2007.06.004_bib31","first-page":"557","article-title":"The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery","volume":"96","author":"Flach","year":"1998","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2007.06.004_bib32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0161-6420(96)30411-9","article-title":"Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice","volume":"103","author":"Francis","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib33","first-page":"5","article-title":"[Mucopolysaccharides and pathogenesis of cortisone glaucoma (author's transl)]","volume":"165","author":"Fran\u00e7ois","year":"1974","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.survophthal.2007.06.004_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00006982-200312000-00029","article-title":"Triamcinolone acetonide-assisted peeling of retinal internal limiting membrane for macular surgery","volume":"23","author":"Fraser","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00006982-200312000-00004","article-title":"Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy","volume":"23","author":"Furino","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib36","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(66)90954-8","article-title":"Methylprednisolone in the treatment of exophthalmos","volume":"1","author":"Garber","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2007.06.004_bib37","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","article-title":"Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study","volume":"100","author":"Gass","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bjo.67.7.487","article-title":"Steroid responsiveness in connective tissue diseases","volume":"67","author":"Gaston","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2004.07.017","article-title":"Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract","volume":"112","author":"Gillies","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib40","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archopht.121.5.667","article-title":"A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results","volume":"121","author":"Gillies","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(87)33443-8","article-title":"Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction","volume":"94","author":"Glaser","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib42","first-page":"631","article-title":"[Surgical extraction of subretinal pseudotumors in age related macular degeneration. Clinical, morphologic and immunohistochemical results]","volume":"92","author":"Heidenkummer","year":"1995","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2007.06.004_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-9394(14)73759-6","article-title":"The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis","volume":"120","author":"Helm","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9394(72)90916-6","article-title":"Intractable intraocular hypertension induced by repository triamcinolone acetonide","volume":"74","author":"Herschler","year":"1972","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib45","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9394(76)90669-3","article-title":"Increased intraocular pressure induced by repository corticosteroids","volume":"82","author":"Herschler","year":"1976","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib46","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","article-title":"Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations","volume":"101","author":"Hida","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib47","first-page":"18","article-title":"Subcutaneous steroid injection as treatment for chalazion: prospective case series","volume":"8","author":"Ho","year":"2002","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.survophthal.2007.06.004_bib48","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","article-title":"Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis","volume":"121","author":"Holsclaw","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1076\/soph.18.2.67.15860","article-title":"Treatment of central retinal vein occlusion with triamcinolone acetonide: an optical coherence tomography study","volume":"18","author":"Ip","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib50","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archopht.122.8.1131","article-title":"Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion","volume":"122","author":"Ip","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib51","first-page":"385","article-title":"Posterior sub-Tenon's injections of corticosteroids in uveitis patients with cystoid macular edema","volume":"32","author":"Jennings","year":"1988","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib52","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archopht.122.2.218","article-title":"Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration","volume":"122","author":"Jonas","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2004.02.025","article-title":"Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema","volume":"138","author":"Jonas","year":"2004","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.eye.6701438","article-title":"Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study","volume":"19","author":"Jonas","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2007.06.004_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/bjo.87.1.24","article-title":"Intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"87","author":"Jonas","year":"2003","journal-title":"Br J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib56","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","article-title":"Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema","volume":"136","author":"Jonas","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib57","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1136\/bjo.2003.039552","article-title":"Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration","volume":"88","author":"Jonas","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib58","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","article-title":"Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema","volume":"132","author":"Jonas","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib59","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.86.12.1450-a","article-title":"Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil","volume":"86","author":"Jonas","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib60","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2003.08.012","article-title":"Intraocular availability of triamcinolone acetonide after intravitreal injection","volume":"137","author":"Jonas","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000093796","article-title":"Intravitreal triamcinolone acetonide: a change in a paradigm","volume":"38","author":"Jonas","year":"2006","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2007.06.004_bib62","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1007\/s00417-005-0251-9","article-title":"Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density","volume":"244","author":"Kai","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib63","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/archopht.1995.01100070041022","article-title":"Biochemical quantification of triamcinolone in subconjunctival depots","volume":"113","author":"Kalina","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/archopht.1969.00990010790006","article-title":"Increased intraocular pressure following subconjunctival corticosteroid administration","volume":"81","author":"Kalina","year":"1969","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib65","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.eye.6701512","article-title":"Intravitreal triamcinolone as a primary therapy in diabetic macular oedema","volume":"19","author":"Karacorlu","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2007.06.004_bib66","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1395-3907.2003.0146.x","article-title":"Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema","volume":"81","author":"Karacorlu","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2007.06.004_bib67","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0002-9394(03)00782-7","article-title":"Triamcinolone acetonide-assisted peeling of the internal limiting membrane","volume":"137","author":"Kimura","year":"2004","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3928\/1542-8877-20001101-07","article-title":"Retinal toxicity of triamcinolone acetonide in silicone-filled eyes","volume":"31","author":"Kivilcim","year":"2000","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.survophthal.2007.06.004_bib69","first-page":"4271","article-title":"Vascular effects of photodynamic therapy","volume":"21","author":"Krammer","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.survophthal.2007.06.004_bib70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1442-9071.2004.00903.x","article-title":"Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study","volume":"32","author":"Lam","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib71","article-title":"The selection of adrenocorticosteroid preparations","volume":"71","author":"Kreines","year":"1975","journal-title":"Ohio State Med J"},{"key":"10.1016\/j.survophthal.2007.06.004_bib72","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jop.1999.15.425","article-title":"Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization","volume":"15","author":"Martidis","year":"1999","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.survophthal.2007.06.004_bib74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib75","first-page":"525","article-title":"Increased concentration of glucocorticoid receptors in rabbit iris\u2013ciliary body compared to rabbit liver","volume":"23","author":"McCarty","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib76","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","article-title":"The lack of toxicity of intravitreally administered triamcinolone acetonide","volume":"91","author":"McCuen","year":"1981","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/112067210401400407","article-title":"Intravitreal triamcinolone acetonide: valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema","volume":"14","author":"Micelli Ferrari","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib78","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3928\/1542-8877-19981101-12","article-title":"Accidental subretinal injection of triamcinolone acetonide","volume":"29","author":"Modarres","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.survophthal.2007.06.004_bib79","first-page":"64","article-title":"Complications of intravitreal triamcinolone injection","volume":"4","author":"Moshfeghi","year":"2004","journal-title":"Rev Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajo.2004.03.025","article-title":"Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema","volume":"138","author":"Moshfeghi","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib81","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0002-9394(03)00483-5","article-title":"Acute endophthalmitis following intravitreal triamcinolone acetonide injection","volume":"136","author":"Moshfeghi","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib82","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0002-9394(99)80085-3","article-title":"The effect of deep posterior subtenon injection of corticosteroids on intraocular pressure","volume":"125","author":"Mueller","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib83","first-page":"968","article-title":"Three methods of treatment of chalazia in children","volume":"22","author":"Mustafa","year":"2001","journal-title":"Saudi Med J"},{"key":"10.1016\/j.survophthal.2007.06.004_bib84","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00006982-200310000-00014","article-title":"Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection","volume":"23","author":"Nelson","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib85","first-page":"695","article-title":"Periocular injection of steroids","volume":"76","author":"Nozik","year":"1976","journal-title":"Trans Am Acad Ophth Otol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib86","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajo.2006.05.041","article-title":"Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection","volume":"142","author":"Ober","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib87","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.87.8.968","article-title":"Trans-Tenon's retrobulbar triamcinolone infusion for the treatment of uveitis","volume":"87","author":"Okada","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib88","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/112067210401400615","article-title":"Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema","volume":"14","author":"Ozkiris","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","article-title":"Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion","volume":"136","author":"Park","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib90","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(97)30019-0","article-title":"Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis","volume":"104","author":"Park","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib91","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.2000.01316.x","article-title":"Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration","volume":"121","author":"Penfold","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib92","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1442-9071.1995.tb00179.x","article-title":"Exudative macular degeneration and intravitreal triamcinolone. A pilot study","volume":"23","author":"Penfold","year":"1995","journal-title":"Aust NZ J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib93","first-page":"3125","article-title":"Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells","volume":"43","author":"Penfold","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib94","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","article-title":"Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy","volume":"20","author":"Peyman","year":"2000","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2007.06.004_bib95","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archopht.1974.03900060428017","article-title":"Bacterial endophthalmitis. Treatment with intraocular injection of gentamicin and dexamethasone","volume":"91","author":"Peyman","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib96","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9394(14)78111-5","article-title":"Intralesional corticosteroid therapy of chalazia","volume":"85","author":"Pizzarello","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib97","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0002-9394(66)92551-7","article-title":"High myopia and primary open-angle glaucoma","volume":"62","author":"Podos","year":"1966","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib98","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","article-title":"Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome","volume":"136","author":"Rechtman","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib99","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bjo.2003.027177","article-title":"Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration","volume":"88","author":"Rechtman","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0733-8635(18)30318-8","article-title":"Ocular effects of topical and systemic steroids","volume":"10","author":"Renfro","year":"1992","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2007.06.004_bib101","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjo.2006.090340","article-title":"Intraocular pressure alterations following intravitreal triamcinolone acetonide","volume":"90","author":"Rhee","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib102","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/eye.1994.12","article-title":"Orbital floor steroid injections in the treatment of uveitis","volume":"8","author":"Riordan-Eva","year":"1994","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2007.06.004_bib103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0014-4835(73)90164-4","article-title":"Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma","volume":"17","author":"Rohen","year":"1973","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2007.06.004_bib104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00417-004-0958-z","article-title":"Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid","volume":"243","author":"Rosenblatt","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib105","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1034\/j.1600-0420.1999.770505.x","article-title":"Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis","volume":"77","author":"Saini","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2007.06.004_bib106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00417-002-0454-2","article-title":"Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown","volume":"240","author":"Sakamoto","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib107","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0161-6420(02)01103-X","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series","volume":"109","author":"Saperstein","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib108","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-9394(82)90130-1","article-title":"The clearance of intravitreal triamcinolone acetonide","volume":"93","author":"Schindler","year":"1982","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib109","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00003226-200405000-00016","article-title":"Pseudohypopyon following intravitreal triamcinolone acetonide injection","volume":"23","author":"Sharma","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2007.06.004_bib110","series-title":"Shields' Textbook of Glaucoma","author":"Shields","year":"1998"},{"key":"10.1016\/j.survophthal.2007.06.004_bib111","first-page":"160","article-title":"Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis","volume":"50","author":"Singh","year":"2001","journal-title":"Ind J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib112","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib113","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.ajo.2004.05.073","article-title":"Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/00015559850135751","article-title":"Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging","volume":"78","author":"Sommer","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib115","first-page":"353","article-title":"Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects","volume":"75","author":"Spaeth","year":"1977","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.survophthal.2007.06.004_bib116","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","article-title":"Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization","volume":"110","author":"Spaide","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08820539309060220","article-title":"Cystoid macular edema after cataract surgery","volume":"8","author":"Spaide","year":"1993","journal-title":"Sem Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib118","first-page":"147","article-title":"Nuclear translocation of the cytoplasmic glucocorticoid receptor in the iris-ciliary body and adjacent corneoscleral tissue of the rabbit following topical administration of various glucocorticoids. A rapid screening method for glucocorticoid activity","volume":"24","author":"Southren","year":"1983","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib119","first-page":"393","article-title":"5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma","volume":"26","author":"Southren","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2007.06.004_bib120","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/eye.1998.168","article-title":"Posterior sub-Tenon's triamcinolone injections in the treatment of uveitis","volume":"12","author":"Tanner","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2007.06.004_bib121","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0002-9394(14)75196-7","article-title":"Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide","volume":"90","author":"Tano","year":"1980","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib122","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0002-9394(81)90171-9","article-title":"Glucocorticosteroid inhibition of intraocular proliferation after injury","volume":"91","author":"Tano","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib123","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0161-6420(95)30849-4","article-title":"___: Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib124","unstructured":"The SCORE Study Clinical Studies Database, NEI: http:\/\/www.nei.nih.gov\/neitrials\/viewStudyWeb.aspx?id=99. Accessed 7\/9\/07"},{"key":"10.1016\/j.survophthal.2007.06.004_bib125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5694\/j.1326-5377.1974.tb70934.x","article-title":"Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy","volume":"2","author":"Thomas","year":"1974","journal-title":"Med J Aust"},{"key":"10.1016\/j.survophthal.2007.06.004_bib126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib127","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.63.9.646","article-title":"Ocular changes in rabbits with corticosteroid-induced ocular hypertension","volume":"63","author":"Ticho","year":"1979","journal-title":"Br\u00a0J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib129","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0161-6420(95)30963-3","article-title":"Therapy of nonnecrotizing anterior scleritis with subconjunctival corticosteroid injection","volume":"102","author":"Tu","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib130","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1167\/iovs.02-1115","article-title":"Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor","volume":"44","author":"Schmidt-Erfurth","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib131","first-page":"339","article-title":"Intralesional corticosteroid treatment of chalazia","volume":"18","author":"Vidaurri","year":"1986","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib132","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2340\/0001555560541542","article-title":"Glaucoma and amaurosis associated with long-term application of topical corticosteroids to the eyelids","volume":"60","author":"Vie","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib133","first-page":"403","article-title":"Detection of glucocorticoid receptors in cultured human trabecular cells","volume":"21","author":"Weinreb","year":"1981","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2007.06.004_bib134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0039-6257(92)90115-A","article-title":"Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration","volume":"36","author":"Wiedemann","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archopht.1988.01060130810028","article-title":"Angiographic cystoid macular edema after posterior chamber lens implantation","volume":"106","author":"Wright","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib136","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajo.2004.05.033","article-title":"Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery","volume":"138","author":"Yamakiri","year":"2004","journal-title":"Am J\u00a0Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib137","first-page":"71","article-title":"Posterior sub-Tenon injections of repository corticosteroids in uveitis patients with cystoid macular edema","volume":"39","author":"Yoshikawa","year":"1995","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2007.06.004_bib138","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0161-6420(01)01018-1","article-title":"A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis","volume":"109","author":"Zamir","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2007.06.004_bib139","series-title":"Textbook of ocular pharmacology","author":"Zimmerman","year":"1997"},{"key":"10.1016\/j.survophthal.2007.06.004_bib140","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archderm.1976.01630330080032","article-title":"Glaucoma from topically applied steroids","volume":"112","author":"Zugerman","year":"1976","journal-title":"Arch Dermatol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625707001270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625707001270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:32:10Z","timestamp":1758540730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625707001270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0039625707001270"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2007.06.004","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triamcinolone Acetonide in Ocular Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2007.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}